Current Ratio of Keros Therapeutics, Inc. from 30 Sep 2020 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Keros Therapeutics, Inc. quarterly Current Ratio in % history and change rate from 30 Sep 2020 to 31 Dec 2025.
  • Keros Therapeutics, Inc. Current Ratio for the quarter ending 31 Dec 2025 was 2131%, a 0.88% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Keros Therapeutics, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q4 2025 2131% +18% +0.88% 31 Dec 2025
Q3 2025 2229% +306% +16% 30 Sep 2025
Q2 2025 2017% +107% +5.6% 30 Jun 2025
Q1 2025 1993% +83% +4.4% 31 Mar 2025
Q4 2024 2112% +256% +14% 31 Dec 2024
Q3 2024 1923% -62% -3.1% 30 Sep 2024
Q2 2024 1910% -150% -7.3% 30 Jun 2024
Q1 2024 1910% +17% +0.91% 31 Mar 2024
Q4 2023 1856% +71% +4% 31 Dec 2023
Q3 2023 1986% +102% +5.4% 30 Sep 2023
Q2 2023 2060% +196% +11% 30 Jun 2023
Q1 2023 1892% -368% -16% 31 Mar 2023
Q4 2022 1786% -692% -28% 31 Dec 2022
Q3 2022 1884% -974% -34% 30 Sep 2022
Q2 2022 1864% -1093% -37% 30 Jun 2022
Q1 2022 2260% -327% -13% 31 Mar 2022
Q4 2021 2478% +515% +26% 31 Dec 2021
Q3 2021 2858% +1619% +131% 30 Sep 2021
Q2 2021 2957% 30 Jun 2021
Q1 2021 2587% 31 Mar 2021
Q4 2020 1963% 31 Dec 2020
Q3 2020 1239% 30 Sep 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.